Lorena Landuzzi

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Cells

Cancers

BMC cancer

Cancer immunology research

IRCCS Istituto Ortopedico Rizzoli

This page only lists publications with an associated author ORCID identifier.

Affiliation History

IRCCS Istituto Ortopedico Rizzoli Feb 01 2003

Italy

Dirigente Biologo :: Laboratorio Oncologia Sperimentale

Publications

Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
IL-1 Family Members in Bone Sarcomas. Cells 13 (3) (2024)
Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
IL-1 Family Members in Bone Sarcomas. Cells 13 (3) (2024)
Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
IL-1 Family Members in Bone Sarcomas. Cells 13 (3) (2024)
Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
IL-1 Family Members in Bone Sarcomas. Cells 13 (3) (2024)
Lorena Landuzzi, Francesca Ruzzi, Evelin Pellegrini, Pier-Luigi Lollini, Katia Scotlandi, Maria Cristina Manara
IL-1 Family Members in Bone Sarcomas. Cells 13 (3) (2024)
Maria Cristina Manara, Cristina Manferdini, Camilla Cristalli, Marianna Carrabotta, Spartaco Santi, Alessandra De Feo, Giulia Caldoni, Michela Pasello, Lorena Landuzzi, Pier-Luigi Lollini, Francesca Salamanna, Sabrina Dominici, Valentina Fiori, Mauro Magnani, Gina Lisignoli, Katia Scotlandi
Engagement of CD99 activates distinct programs in Ewing sarcoma and macrophages. Cancer immunology research (2023)
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research. Cancers 15 (3) (2023)
Lorena Landuzzi, Maria Cristina Manara, Laura Pazzaglia, Pier-Luigi Lollini, Katia Scotlandi
Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma. Cancers 15 (15) (2023)
Lorena Landuzzi, Francesca Ruzzi, Pier-Luigi Lollini, Katia Scotlandi
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research. Cancers 15 (3) (2023)
Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, Laura Scalambra, Francesco Gelsomino, Andrea Ardizzoni, Patrizia Nanni, Pier-Luigi Lollini, Arianna Palladini
IFN-γ and CD38 in Hyperprogressive Cancer Development. Cancers 13 (2) (2021)
Carla De Giovanni, Patrizia Nanni, Lorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, Stefania Croci, Arianna Palladini, Pier-Luigi Lollini
Immune targeting of autocrine IGF2 hampers rhabdomyosarcoma growth and metastasis. BMC cancer 19 (1) (2019)

Lorena Landuzzi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Lorena Landuzzi